Clinical Trials
3 trialsNCT06424301 2025-06-26
Targeting NUDT21 siRNA Drugs for Patients With Refractory Retinoblastoma
Eye & ENT Hospital of Fudan University
Phase EARLY_PHASE1 Recruiting
NCT06972602 2025-05-15
High-dose Topotecan for Retinoblastoma With Recurrent or Refractory Vitreous Seed
Eye & ENT Hospital of Fudan University
Phase EARLY_PHASE1 Recruiting
NCT01466855 2020-09-14
IARB1
Children's Hospital Medical Center, Cincinnati
Phase EARLY_PHASE1 Terminated